The world's leading contrast agent for X-ray and has been used in over 300 million patients worldwide. Its indications include a broad range of intravascular diagnostic procedures such as coronary angiography, spinal cord imaging and body-cavity procedure.
• Available in over 100 countries
• Providing high quality contrast for more than
25
years
• Reported in over 6,500 published clinical
articles
• Reports to the FDA indicate that Omnipaque is at least as well tolerated as other LOCM (ioxaglate, iopamidol, ioversol)[1]
• Both the ESUR, and analysis of data from reports to the FDA, group all LOCM together as a class when considering safety[2,3]
Visit www.medcyclopaedia.com, an invaluable online resource for all medical professionals, where you can access the internet library, use interactive e-learning, or download the desktop search tool.